330PPharmacokinetics (PK), safety, and efficacy of [fam-] trastuzumab deruxtecan with OATP1B/CYP3A inhibitors in subjects with HER2-expressing advanced solid tumoursY-J Bang,M Karayama, M Takahashi,J Watanabe,H Minami,N Yamamoto,I Kinoshita,C C Lin,Y H Im, T Fujiki, I Achiwa, E Kamiyama,Y Okuda,C Lee,S TakahashiANNALS OF ONCOLOGY（2019）引用 5|浏览16暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
